The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Improving Blood Pressure Control Through Pharmacist Interventions: A Meta‐Analysis of Randomized Controlled Trials
Open accessAbstract
Background: Control of blood pressure ( BP ) remains a major challenge in primary care. Innovative interventions to improve BP control are therefore needed. By updating and combining data from 2 previous systematic reviews, we assess the effect of pharmacist interventions on BP and identify potential determinants of heterogeneity. Methods and Results: Randomized controlled trials ( RCT s) assessing the effect of pharmacist interventions on BP among outpatients with or without diabetes were identified from MEDLINE , EMBASE , CINAHL , and CENTRAL databases. Weighted mean differences in BP were estimated using random effect models. Prediction intervals ( PI ) were computed to better express uncertainties in the effect estimates. Thirty‐nine RCT s were included with 14 224 patients. Pharmacist interventions mainly included patient education, feedback to physician, and medication management. Compared with usual care, pharmacist interventions showed greater reduction in systolic BP (−7.6 mm Hg, 95% CI : −9.0 to −6.3; I 2 = 67%) and diastolic BP (−3.9 mm Hg, 95% CI : −5.1 to −2.8; I 2 = 83%). The 95% PI ranged from −13.9 to −1.4 mm Hg for systolic BP and from −9.9 to +2.0 mm Hg for diastolic BP . The effect tended to be larger if the intervention was led by the pharmacist and was done at least monthly. Conclusions: Pharmacist interventions – alone or in collaboration with other healthcare professionals – improved BP management. Nevertheless, pharmacist interventions had differential effects on BP , from very large to modest or no effect; and determinants of heterogeneity could not be identified. Determining the most efficient, cost‐effective, and least time‐consuming intervention should be addressed with further research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series
(2008) · doi:10.1002/9780470712184 · Cited by 25,048
Wang, G., Ma, R., Qiao, G., Wada, K., Aizawa, Y., & Satoh, T. (2015) · Integrative Medicine International · doi:10.1159/000368408 · Cited by 18,657
Borenstein, M., Hedges, L. V., Higgins, J. P. T., & Rothstein, H. R. (2021) · doi:10.1002/9781119558378 · Cited by 9,799
Interpretation of random effects meta-analyses
Riley, R. D., Higgins, J. P. T., & Deeks, J. J. (2011) · BMJ · doi:10.1136/bmj.d549 · Cited by 2,884
Global burden of blood-pressure-related disease, 2001
Lawes, C. M., Hoorn, S. V., & Rodgers, A. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60655-8 · Cited by 2,330
The case of the misleading funnel plot
Lau, J., Ioannidis, J. P. A., Terrin, N., Schmid, C. H., & Olkin, I. (2006) · BMJ · doi:10.1136/bmj.333.7568.597 · Cited by 1,766
Hypertension Treatment and Control in Five European Countries, Canada, and the United States
Wolf-Maier, K., Cooper, R. S., Kramer, H., Banegas, J. R., Giampaoli, S., Joffres, M. R., Poulter, N., Primatesta, P., Stegmayr, B., & Thamm, M. (2004) · Hypertension · doi:10.1161/01.hyp.0000103630.72812.10 · Cited by 1,083
US Pharmacists' Effect as Team Members on Patient Care: Systematic Review and Meta-Analyses
Chisholm-Burns, M. A., Kim Lee, J., Spivey, C. A., Slack, M., Herrier, R. N., Hall-Lipsy, E., Graff Zivin, J., Abraham, I., Palmer, J., Martin, J. R., et al. (2010) · Medical Care · doi:10.1097/mlr.0b013e3181e57962 · Cited by 809
Lee, J. K., Grace, K. A., & Taylor, A. J. (2006) · JAMA · doi:10.1001/jama.296.21.joc60162 · Cited by 807
Green, B. B. (2008) · JAMA · doi:10.1001/jama.299.24.2857 · Cited by 659
Margolis, K. L., Asche, S. E., Bergdall, A. R., Dehmer, S. P., Groen, S. E., Kadrmas, H. M., Kerby, T. J., Klotzle, K. J., Maciosek, M. V., Michels, R. D., et al. (2013) · JAMA · doi:10.1001/jama.2013.6549 · Cited by 591
Gu, Q., Burt, V. L., Dillon, C. F., & Yoon, S. (2012) · Circulation · doi:10.1161/circulationaha.112.096156 · Cited by 521
The Effect of Clinical Pharmacy Services on Patients with Essential Hypertension
McKENNEY, J. M., SLINING, J. M., HENDERSON, H. R., DEVINS, D., & BARR, M. (1973) · Circulation · doi:10.1161/01.cir.48.5.1104 · Cited by 340
Koshman, S. L. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.7.687 · Cited by 336
Physician and Pharmacist Collaboration to Improve Blood Pressure Control
Carter, B. L. (2009) · Archives of Internal Medicine · doi:10.1001/archinternmed.2009.358 · Cited by 311
Santschi, V. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.399 · Cited by 296
Self-citationRothman, R. L., Malone, R., Bryant, B., Shintani, A. K., Crigler, B., Dewalt, D. A., Dittus, R. S., Weinberger, M., & Pignone, M. P. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.09.017 · Cited by 267
McLean, D. L. (2008) · Archives of Internal Medicine · doi:10.1001/archinte.168.21.2355 · Cited by 234
Impact of pharmacist care in the management of cardiovascular disease risk factors
(2012) · Clinical Governance: An International Journal · doi:10.1108/cgij.2012.24817aaa.011 · Cited by 212
Carter, B. L., Bergus, G. R., Dawson, J. D., Farris, K. B., Doucette, W. R., Chrischilles, E. A., & Hartz, A. J. (2008) · The Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2008.07434.x · Cited by 206
Physician‐Pharmacist Comanagement of Hypertension: A Randomized, Comparative Trial
Borenstein, J. E., Graber, G., Saltiel, E., Wallace, J., Ryu, S., Jackson, A., Deutsch, S., & Weingarten, S. R. (2003) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.23.2.209.32096 · Cited by 200
Improving Blood Pressure Control in a Pharmacist‐Managed Hypertension Clinic
Vivian, E. M. (2002) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.22.17.1533.34127 · Cited by 193
The Hypertension Team: The Role of the Pharmacist, Nurse, and Teamwork in Hypertension Therapy
Carter, B. L., Bosworth, H. B., & Green, B. B. (2011) · Journal of Clinical Hypertension · doi:10.1111/j.1751-7176.2011.00542.x · Cited by 190
Pharmacist intervention program to enhance hypertension control: a randomised controlled trial
Morgado, M., Rolo, S., & Castelo-Branco, M. (2011) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-010-9474-x · Cited by 190
Effect of a Pharmaceutical Care Program on Vascular Risk Factors in Type 2 Diabetes
Clifford, R. M., Davis, W. A., Batty, K. T., & Davis, T. M. E. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.771 · Cited by 188
Hypertension outcomes through blood pressure monitoring and evaluation by pharmacists (HOME study)
Zillich, A. J., Sutherland, J. M., Kumbera, P. A., & Carter, B. L. (2005) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2005.0226.x · Cited by 185
Mehos, B. M., Saseen, J. J., & MacLaughlin, E. J. (2000) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.20.17.1384.34891 · Cited by 183
Influence of pharmaceutical care on health outcomes in patients with Type 2 diabetes mellitus
Al Mazroui, N. R., Kamal, M. M., Ghabash, N. M., Yacout, T. A., Kole, P. L., & McElnay, J. C. (2009) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2009.03391.x · Cited by 175
Hunt, J. S., Siemienczuk, J., Pape, G., Rozenfeld, Y., MacKay, J., LeBlanc, B. H., & Touchette, D. (2008) · Journal of General Internal Medicine · doi:10.1007/s11606-008-0791-x · Cited by 171
Jarab, A. S., Alqudah, S. G., Mukattash, T. L., Shattat, G., & Al-Qirim, T. (2012) · Journal of Managed Care Pharmacy · doi:10.18553/jmcp.2012.18.7.516 · Cited by 168
Edelman, D., Fredrickson, S. K., Melnyk, S. D., Coffman, C. J., Jeffreys, A. S., Datta, S., Jackson, G. L., Harris, A. C., Hamilton, N. S., Stewart, H., et al. (2010) · Annals of Internal Medicine · doi:10.7326/0003-4819-152-11-201006010-00001 · Cited by 164
Magid, D. J., Olson, K. L., Billups, S. J., Wagner, N. M., Lyons, E. E., & Kroner, B. A. (2013) · Circulation: Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.112.968172 · Cited by 158
Outcomes of pharmacist-managed diabetes care services in a community health center
Scott, D. M., Boyd, S. T., Stephan, M., Augustine, S. C., & Reardon, T. P. (2006) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp060040 · Cited by 152
Solomon, D. K., Portner, T. S., Bass, G. E., Gourley, D. R., Gourley, G. A., Holt, J. M., Wicke, W. R., Braden, R. L., Eberle, T. N., Self, T. H., et al. (1998) · Journal of the American Pharmaceutical Association (1996) · doi:10.1016/s1086-5802(16)30371-0 · Cited by 147
Pharmacist Interventions to Improve Cardiovascular Disease Risk Factors in Diabetes
Santschi, V., Chiolero, A., Paradis, G., Colosimo, A. L., & Burnand, B. (2012) · Diabetes Care · doi:10.2337/dc12-0369 · Cited by 145 · cited 7×
“Methods Data were updated and combined from 2 previous systematic reviews of RCTs in which we assessed the effect of pharmacist interventions on CVD risk factors among outpatients.(9,10) Both reviews were conducted following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) recommendation…”
BackgroundMethodResultInfluentialSelf-citationU.S. Preventive Services Task Force* (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-11-200712040-00009 · Cited by 144
Comparing standard care with a physician and pharmacist team approach for uncontrolled hypertension
Bogden, P. E., Abbott, R. D., Williamson, P., Onopa, J., & Koontz, L. M. (1998) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.1998.00225.x · Cited by 143
Pharmacist Involvement in Primary Care Improves Hypertensive Patient Clinical Outcomes
Sookaneknun, P., Richards, R. M., Sanguansermsri, J., & Teerasut, C. (2004) · Annals of Pharmacotherapy · doi:10.1345/aph.1d605 · Cited by 141
Evaluation of a Pharmaceutical Care Program for Hypertensive Patients in Rural Portugal
Garçao, J. A., & Cabrita, J. (2002) · Journal of the American Pharmaceutical Association (1996) · doi:10.1331/108658002762063691 · Cited by 129
Evaluation of a hypertension medication therapy management program in patients with diabetes
Planas, L. G., Crosby, K. M., Mitchell, K. D., & Farmer, K. C. (2009) · Journal of the American Pharmacists Association · doi:10.1331/japha.2009.08164 · Cited by 128
Fornos, J. A., de Andrés, N. F., Andrés, J. C., Guerra, M., & Egea, B. (2006) · Pharmacy World & Science · doi:10.1007/s11096-006-9003-0 · Cited by 124
Simpson, S. H., Majumdar, S. R., Tsuyuki, R. T., Lewanczuk, R. Z., Spooner, R., & Johnson, J. A. (2010) · Diabetes Care · doi:10.2337/dc10-1294 · Cited by 124
The Effect of Community Pharmacy–Based Interventions on Patient Health Outcomes: A Systematic Review
Blalock, S. J., Roberts, A. W., Lauffenburger, J. C., Thompson, T., & O’Connor, S. K. (2012) · Medical Care Research and Review · doi:10.1177/1077558712459215 · Cited by 120
Pharmaceutical care program for type 2 diabetes patients in Brazil: a randomised controlled trial
Mourão, A. D. O. M., Ferreira, W. R., Martins, M. A. P., Reis, A. M. M., Carrillo, M. R. G. G., Grabe‐Guimarães, A., & Ev, L. D. S. (2012) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-012-9710-7 · Cited by 113
Pharmacoeconomic Evaluation of a Pharmacist‐Managed Hypertension Clinic
Okamoto, M. P., & Nakahiro, R. K. (2001) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.21.17.1337.34424 · Cited by 110
Mossialos, E., Naci, H., & Courtin, E. (2013) · Health Policy · doi:10.1016/j.healthpol.2013.04.003 · Cited by 104 · cited 1×
“Our findings that the effect on BP was slightly greater if the intervention was led by the pharmacist differ to some extend from a recent umbrella review of systematic reviews evaluating the effectiveness of community pharmacist intervention.(58) Mossialos et al(58) reported mixed or inconclusive evidence in support o…”
ResultA multimodal blood pressure control intervention in 3 healthcare systems.
Magid, D. J., Ho, P. M., Olson, K. L., Brand, D. W., Welch, L. K., Snow, K. E., Lambert‐Kerzner, A., Plomondon, M. E., & Havranek, E. P. (2011) · PubMed · Cited by 95
A Pharmacist Care Program: Positive Impact on Cardiac Risk in Patients With Type 2 Diabetes
Chan, C.-W., Siu, S., Wong, C. K. W., & Lee, V. W. Y. (2011) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248410396216 · Cited by 84
DeCastro, M. L., Fuchs, F. D., COSTASANTOS, M., Maximiliano, P., Gus, M., BELTRAMIMOREIRA, L., & Ferreira, M. B. C. (2006) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.11.009 · Cited by 82
Santschi, V., Rodondi, N., Bugnon, O., & Burnier, M. (2008) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2007.12.007 · Cited by 75
Self-citationMeta-analyses: with confidence or prediction intervals?
Chioléro, A., Santschi, V., Burnand, B., Platt, R. W., & Paradis, G. (2012) · European Journal of Epidemiology · doi:10.1007/s10654-012-9738-y · Cited by 72
Self-citationBlood pressure-lowering efficacy of loop diuretics for primary hypertension
Musini, V. M., Rezapour, P., Wright, J. M., Bassett, K. L., & Jauca, C. D. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003825.pub4 · Cited by 62
Kraemer, D. F., Kradjan, W. A., Bianco, T. M., & Low, J. A. (2011) · Journal of Pharmacy Practice · doi:10.1177/0897190011418513 · Cited by 56
Hennessy, S., Leonard, C. E., Yang, W. P., Kimmel, S. E., Townsend, R. R., Wasserstein, A. G., Have, T. R. T., & Bilker, W. B. (2006) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.26.9.1342 · Cited by 41
Pharmacist‐Led Cardiac Risk Reduction Model
Taveira, T. H., Wu, W., Martin, O. J., Schleinitz, M. D., Friedmann, P. D., & Sharma, S. C. (2006) · Preventive Cardiology · doi:10.1111/j.1520-037x.2006.05339.x · Cited by 37
Alcohol Electronic Screening and Brief Intervention
Community Preventive Services Task Force (2016) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2016.04.012 · Cited by 30
Effects of Heart Rate Changes on Arterial Distensibility in Humans
O’Rourke, M. F., & Adji, A. I. (2004) · Hypertension · doi:10.1161/01.hyp.0000116289.91160.73 · Cited by 22
Wang, J., Wu, J., Jun-fen, Y., Zhuang, Y., Chen, J., Qian, W., Tian, J., Chen, X., She, D., & Peng, F. (2010) · Clinical Research and Regulatory Affairs · doi:10.3109/10601333.2010.539230 · Cited by 19
Borenstein, M., Hedges, L. V., Higgins, J. P. T., et al. (2009) · doi:10.1002/9780470743386.ch17 · Cited by 17
Notes on Subgroup Analyses and Meta‐Regression
(2009) · Introduction to Meta‐Analysis · doi:10.1002/9780470743386.ch21 · Cited by 13
Cited by
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000066 · Cited by 4,347
Mancia, G., Kreutz, R., Brunström, M., Burnier, M., Grassi, G., Januszewicz, A., Muiesan, M. L., Tsioufis, K., Agabiti-Rosei, E., Algharably, E. A. E., et al. (2023) · Journal of Hypertension · doi:10.1097/hjh.0000000000003480 · Cited by 3,473
Self-citationMeasurement of Blood Pressure in Humans: A Scientific Statement From the American Heart Association
Muntner, P., Shimbo, D., Carey, R. M., Charleston, J. B., Gaillard, T., Misra, S., Myers, M. G., Ogedegbe, G., Schwartz, J. E., Townsend, R. R., et al. (2019) · Hypertension · doi:10.1161/hyp.0000000000000087 · Cited by 1,512
Metadata
- Authors
- Santschi, V., Chiolero, A., Colosimo, A. L., Platt, R. W., Taffé, P., Burnier, M., Burnand, B., & Paradis, G.
- Venue
- Journal of the American Heart Association
- Published
- 2014-03-24
- Volume
- 3
- Issue
- 2
- Pages
- e000718-e000718
- ISSN
- 2047-9980 (ISSN-L)
- OpenAlex
- W2133580565
- Cited by
- 349
- References
- 63
- FWCI
- 29.09
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.